Diagnosis-prescription studies – important steps towards a national drug prescription statistics in Norway
DOI:
https://doi.org/10.5324/nje.v11i1.533Sammendrag
ABSTRACT
In the first part of this article, drug utilization and prescribing practice is discussed as seen from a
Norwegian general practice perspective. Which are the data sources available? What kind of studies
have been performed? Prescription-diagnosis studies are reviewed, in particular the Møre & Romsdal
Prescription Study (MRPS). Because the wholesales drug statistics do not include information about
neither patients, prescribers or diagnoses, there is a current need for establishing a more comprehensive
statistics giving wider and deeper insights into the prescribing and utilization of drugs in the Norwegian
society. The proposed Norwegian prescription statistics is discussed in relation to previous experiences
from prescription-diagnosis studies and current needs for research and statistics in the field. Some
examples are given illustrating why the 11-digit person number probably should be included in the
database. Lack of diagnostic information may to some extent be compensated for by introducing a more
differentiated list of diagnoses for the drugs reimbursed. The use of data from this statistics for quality
assurance in e.g. general practice is discussed. Finally, some suggestions are given for how the Norwegian
prescription statistics may be organised.
Downloads
Nedlastinger
Publisert
Hvordan referere
Utgave
Seksjon
Lisens
Norsk Epidemiologi licenses all content of the journal under a Creative Commons Attribution (CC-BY) licence. This means, among other things, that anyone is free to copy and distribute the content, as long as they give proper credit to the author(s) and the journal. For further information, see Creative Commons website for human readable or lawyer readable versions.
Authors who publish with this journal agree to the following terms:
1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
